Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
358 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05792254 | Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer | unknown | N/A | 30 | Ruijin HospitalOTHER | 0 | Mar 31, 2023 | clinicaltrials |
| NCT05351346 | Genotype-guided Treatment in DLBCL | unknown | Phase 3 | 1,100 | Ruijin HospitalOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT04088422 |
| Cell Free DNA in Mature B-cell Lymphoma |
| recruiting |
| — |
| 320 |
| Ruijin HospitalOTHER |
| 1 |
| Feb 24, 2023 |
| clinicaltrials |
| NCT05662553 | ENB Guided MWA Combined With VATS Versus Sequential Surgery for Synchronous Bilateral Multiple Primary Lung Nodules | unknown | N/A | 172 | Ruijin HospitalOTHER | 1 | Jan 10, 2023 | clinicaltrials |
| NCT02942615 | The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy. | unknown | N/A | 220 | Ruijin HospitalOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT05658679 | Radiomics in Pancreatic Cancer | unknown | — | 2,000 | Ruijin HospitalOTHER | 0 | Dec 21, 2022 | clinicaltrials |
| NCT02752815 | Reduced Chemotherapy in Low Risk DLBCL | unknown | Phase 4 | 290 | Ruijin HospitalOTHER | 1 | Dec 5, 2022 | clinicaltrials |
| NCT05101655 | Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma | completed | — | 60 | Ruijin HospitalOTHER | 1 | Nov 15, 2022 | clinicaltrials |
| NCT05559008 | A Umbrella Study in R/R PTCL Guided by Molecular Subtypes | unknown | Phase 1 / Phase 2 | 116 | Ruijin HospitalOTHER | 1 | Nov 9, 2022 | clinicaltrials |
| NCT03855371 | Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS(PANDA-T0) | unknown | Phase 1 | 5 | Ruijin HospitalOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT05602415 | Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma | unknown | Phase 2 | 41 | Ruijin HospitalOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT02549677 | Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer(ELEGANT) | completed | Phase 4 | 294 | Ruijin HospitalOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT03907800 | Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer(NeoPATH) | unknown | Phase 2 | 100 | Ruijin HospitalOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT05580354 | Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer | unknown | Phase 4 | 42 | Ruijin HospitalOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT04527861 | Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer(CSILS) | recruiting | N/A | 710 | Ruijin HospitalOTHER | 1 | Oct 10, 2022 | clinicaltrials |
| NCT05367856 | Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma | unknown | Phase 2 | 23 | Ruijin HospitalOTHER | 1 | Sep 29, 2022 | clinicaltrials |
| NCT03990532 | Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer | unknown | N/A | 46 | Ruijin HospitalOTHER | 1 | Sep 23, 2022 | clinicaltrials |
| NCT05189782 | Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma | unknown | — | 15 | Ruijin HospitalOTHER | 1 | Aug 31, 2022 | clinicaltrials |
| NCT05486936 | RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam | unknown | — | 195 | Ruijin HospitalOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT03829553 | Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment(HARVEST) | recruiting | Phase 3 | 801 | Ruijin HospitalOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT03853044 | Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell Lymphoma | unknown | Phase 2 | 23 | Ruijin HospitalOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT04480125 | Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy | unknown | Phase 2 | 28 | Ruijin HospitalOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT05334238 | Orelabrutinib Maintenance Therapy After ASCT in Primary Central Nervous System Lymphoma | unknown | Phase 3 | 174 | Ruijin HospitalOTHER | 1 | Apr 19, 2022 | clinicaltrials |
| NCT05201729 | Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer | unknown | — | 30 | Ruijin HospitalOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT05204173 | Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis | unknown | Phase 2 | 30 | Ruijin HospitalOTHER | 1 | Jan 24, 2022 | clinicaltrials |
| NCT05201326 | Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Jan 21, 2022 | clinicaltrials |
| NCT03140189 | Robot-assisted IVOR-LEWIS Esophagectomy(RAILE) | unknown | — | 51 | Ruijin HospitalOTHER | 1 | Jan 19, 2022 | clinicaltrials |
| NCT05185869 | SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer | unknown | Phase 2 | 58 | Ruijin HospitalOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05171530 | Lenvatinib With Taxane Drugs Treatment for Advanced Gastric Cancer | unknown | Phase 1 | 19 | Ruijin HospitalOTHER | 1 | Dec 29, 2021 | clinicaltrials |
| NCT05168254 | Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer | unknown | — | 50 | Ruijin HospitalOTHER | 1 | Dec 23, 2021 | clinicaltrials |
| NCT02787187 | Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended? | completed | N/A | 230 | Ruijin HospitalOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT04789434 | PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT | unknown | Phase 3 | 94 | Ruijin HospitalOTHER | 1 | Nov 22, 2021 | clinicaltrials |
| NCT05097781 | Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients | unknown | Phase 2 | 55 | Ruijin HospitalOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT03010033 | Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer(PREPOSE) | unknown | N/A | 200 | Ruijin HospitalOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT04982900 | Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities(TERMGGO) | unknown | Phase 2 | 138 | Ruijin HospitalOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT04731038 | Combination Therapy for First Line Treatment of Advanced Cervical Cancer | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT04932187 | Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3) | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT04981691 | Anti-mesothelin CAR-T Cells With Advanced Refractory Solid Tumors(Amaretto) | unknown | Phase 1 | 12 | Ruijin HospitalOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT03633539 | Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer(mSILSC) | withdrawn | N/A | 0 | Ruijin HospitalOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT04529603 | The Efficacy of Intraoperative Pulmonary Nodules Localization Guided by Virtual Reality Technology | withdrawn | N/A | 0 | Ruijin HospitalOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT03192904 | Comparison of Energy Instruments and Stapling Device to Dissect Intersegmental Plane in Segmentectomy | terminated | N/A | 70 | Ruijin HospitalOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT03516500 | Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining | completed | N/A | 20 | Ruijin HospitalOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT04211051 | Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules | completed | N/A | 10 | Ruijin HospitalOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT02631239 | MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma | unknown | Phase 3 | 256 | Ruijin HospitalOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT05002686 | Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis | unknown | Phase 2 / Phase 3 | 60 | Ruijin HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05013268 | Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma(TiTanec) | unknown | Phase 1 | 15 | Ruijin HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT04384601 | Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | not yet recruiting | Phase 3 | 246 | Ruijin HospitalOTHER | 1 | Jul 19, 2021 | clinicaltrials |
| NCT04926753 | Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Jun 16, 2021 | clinicaltrials |
| NCT04909775 | Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer | unknown | Phase 2 | 40 | Ruijin HospitalOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04869475 | Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation | unknown | Phase 2 | 20 | Ruijin HospitalOTHER | 1 | May 13, 2021 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials